Clinical Trial Update: Carbon-11 Acetate and Fludeoxyglucose F 18 PET Scan of the Bone in Patients With Metastatic Prostate Cancer That Has Spread to the Bone

View source ↗

Summary

A completed clinical trial evaluating bone imaging in metastatic prostate cancer using Carbon-11 acetate and Fluorodeoxyglucose F-18 PET scans.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Carbon-11 Acetate (11C-acetate)
• Fluorodeoxyglucose F-18 (Fluorodeoxyglucose F-18)

Snippet

Sponsor: University of Washington | Conditions: Metastatic Cancer, Prostate Cancer | Status: COMPLETED